The recent review by Wang and Lippard 1 raises the issue of whether the current trend of shifting away from the development of effective chemotherapy is most beneficial, from a global perspective ...
The current strategies in neuroprotection clinical trials are based either on symptomatic treatment using antiepileptic or pain-killer drugs, such as pregabalin, lamotrigine and gabapentin, or on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback